elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-628CC156-7A15-4DD1-A05B-BA2098AA27A0
Q27852097-628CC156-7A15-4DD1-A05B-BA2098AA27A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-628CC156-7A15-4DD1-A05B-BA2098AA27A0
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P1433
Q27852097-628CC156-7A15-4DD1-A05B-BA2098AA27A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-628CC156-7A15-4DD1-A05B-BA2098AA27A0
rank
NormalRank
type
BestRank
Statement
P1433
Clinical Cancer Research